Clinical Trial Update: Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating diacerein for glycemic control and liver fat in adults with type 2 diabetes and non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease | Phase 3 | Status: COMPLETED